EROSIVE ESOPHAGITIS
Clinical trials for EROSIVE ESOPHAGITIS explained in plain language.
Never miss a new study
Get alerted when new EROSIVE ESOPHAGITIS trials appear
Sign up with your email to follow new studies for EROSIVE ESOPHAGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New GERD drug aims to heal esophagus damage when standard treatments fail
Disease control CompletedThis study tests an experimental drug called X842 in people with severe erosive esophagitis caused by GERD (chronic acid reflux). Participants have either severe esophagus damage (grades C or D) or milder damage that hasn't healed after 8 weeks of standard treatment. The trial co…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE2 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
New pill aims to heal Acid-Damaged esophagus
Disease control CompletedThis study tested a new drug called BLI5100 in 1250 adults with erosive esophagitis, a condition where stomach acid damages the esophagus. Participants took either BLI5100 or a standard PPI (proton pump inhibitor) daily for up to 8 weeks to see if it healed the damage, then for 2…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
GERD drug BLI5100 passes Year-Long safety check
Disease control CompletedThis study checked the safety of taking BLI5100 daily for up to 12 months in 400 adults with gastroesophageal reflux disease (GERD). Participants had either non-erosive reflux disease or healed erosive esophagitis. The main goal was to track any side effects. This is a disease co…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC